Cargando…

Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study

BACKGROUND: Polycystic ovary syndrome (PCOS) is a very common disorder well known to be associated with insulin resistance and metabolic disease. Insulin resistance is likely involved in the promotion of the PCOS reproductive phenotype and may mediate some of the ovarian morphology seen in the disor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reid, Sara Pittenger, Kao, Chia-Ning, Pasch, Lauri, Shinkai, Kanade, Cedars, Marcelle I., Huddleston, Heather G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450099/ https://www.ncbi.nlm.nih.gov/pubmed/28620546 http://dx.doi.org/10.1186/s40738-017-0035-z

Ejemplares similares

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

SAT372 Obstructive Sleep Apnea (OSA) Risk Among Patients With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

OR15-5 Cognitive Function in Reproductive Aged Individuals with Polycystic Ovary Syndrome
por: Cedars, Marcelle, et al.
Publicado: (2022)

Endophenotypic correlates of cognitive function in reproductive-age individuals with polycystic ovary syndrome
por: Huddleston, Heather G., et al.
Publicado: (2022)

Predictors of adequate physical activity within a multiethnic polycystic ovary syndrome patient population: a cross-sectional assessment
por: Huang, David, et al.
Publicado: (2021)

Comparison of metabolic syndrome elements in White and Asian women with polycystic ovary syndrome: results of a regional, American cross-sectional study
por: Chahal, Nikhita, et al.
Publicado: (2020)

Polycystic ovary syndrome is associated with nonalcoholic steatohepatitis in women of reproductive age
por: Maldonado, Stephanie S., et al.
Publicado: (2022)

Association of ethnicity, Fitzpatrick skin type, and hirsutism: A retrospective cross-sectional study of women with polycystic ovarian syndrome()()
por: Afifi, L., et al.
Publicado: (2017)

Learning from Online Video Education (LOVE) improves confidence in fertility treatments: a randomized controlled trial
por: Adeleye, Amanda, et al.
Publicado: (2022)

Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome
por: Lee, Jeong Eun, et al.
Publicado: (2023)

Polycystic ovarian morphology in Thai women of reproductive age with polycystic ovary syndrome
por: Wongwananuruk, Thanyarat, et al.
Publicado: (2020)

ANXIETY DURING THE COVID-19 PANDEMIC: PRELIMINARY FINDINGS FROM THE UCSF ASPIRE STUDY
por: Morris, Jerrine R., et al.
Publicado: (2021)

Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
por: Park, Chan-Hong, et al.
Publicado: (2020)

Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus
por: Miyoshi, Arina, et al.
Publicado: (2013)

Correlation between ovarian morphology and biochemical and hormonal parameters in polycystic ovary syndrome
por: Inan, Cihan, et al.
Publicado: (2016)

Assessing the impact of semen quality on embryo development in an egg donation model
por: Aghajanova, Lusine, et al.
Publicado: (2020)

Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value
por: Song, Do Kyeong, et al.
Publicado: (2017)

Comparative evaluation of sonographic ovarian morphology of Indian women with polycystic ovary syndrome versus those of normal women
por: Ahmed, Sanjeed, et al.
Publicado: (2014)

Statistical Genomic Approach Identifies Association between FSHR Polymorphisms and Polycystic Ovary Morphology in Women with Polycystic Ovary Syndrome
por: Du, Tao, et al.
Publicado: (2015)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
por: Hwang, Kyu Ri, et al.
Publicado: (2013)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Analysis of the effect of hashimoto's thyroiditis and insulin resistance on ovarian volume in patients with polycystic ovary syndrome
por: Gencer, Gülcan, et al.
Publicado: (2023)

The relation of dermcidin with insulin resistance and inflammation in women with polycystic ovary syndrome
por: Akan, Ozden Yildirim, et al.
Publicado: (2022)

Inter-ovarian differences in ultrasound markers of ovarian size in women with polycystic ovary syndrome
por: Chun, Sungwook
Publicado: (2019)

Ovarian HMW adiponectin is associated with folliculogenesis in women with polycystic ovary syndrome
por: Tao, Tao, et al.
Publicado: (2013)

New markers of insulin resistance in polycystic ovary syndrome
por: Polak, K., et al.
Publicado: (2016)

Limitations of insulin resistance assessment in polycystic ovary syndrome
por: Lewandowski, Krzysztof C, et al.
Publicado: (2018)

Elevated ovarian pentraxin 3 in polycystic ovary syndrome
por: Pan, Jiexue, et al.
Publicado: (2021)

Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review
por: Paixão, Larissa, et al.
Publicado: (2017)

Elevated SAA1 promotes the development of insulin resistance in ovarian granulosa cells in polycystic ovary syndrome
por: Zhu, Qinling, et al.
Publicado: (2022)

Impact of Insulin Resistance on Ovarian Sensitivity and Pregnancy Outcomes in Patients with Polycystic Ovary Syndrome Undergoing IVF
por: Luo, Zhuoye, et al.
Publicado: (2023)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
por: Jena, Sweekruti, et al.
Publicado: (2023)

MON-040 11-Oxygenated C19 Steroids in Polycystic Ovarian Syndrome
por: Mody, Armaiti, et al.
Publicado: (2020)

Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome
por: Hamilton, Kristen P, et al.
Publicado: (2019)

Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome
por: Luo, Xi, et al.
Publicado: (2021)

Increased Risk of Polycystic Ovary Syndrome and It’s Comorbidities in Women with Autoimmune Thyroid Disease
por: Ho, Chun-Wei, et al.
Publicado: (2020)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Ovarian Volume in Korean Women with Polycystic Ovary Syndrome and Its Related Factors
por: Han, Young Shin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7udimlm0clvip7tkld90boti4l